相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels
N. Widmer et al.
LEUKEMIA (2007)
Multidrug resistance in epilepsy: a pharmacogenomic update
Sarah K. Tate et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Mechanism of multidrug recognition by MDR1/ABCB1
Yasuhisa Kimura et al.
CANCER SCIENCE (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Moshe Talpaz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry
A. Hamilton et al.
LEUKEMIA (2006)
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate
T Illmer et al.
LEUKEMIA (2004)
Overriding imatinib resistance with a novel ABL kinase inhibitor
NP Shah et al.
SCIENCE (2004)
Distribution of STI-571 to the brain is limited by P-glycoprotein-mediated efflux
HQ Dai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
分享论文
